Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Hypertension
When would you consider referring a patient with resistant hypertension for renal denervation?
Related Questions
What is the optimal BP target for patients with diabetes and hypertension to reduce their risk of MI/stroke?
Do you recommend transitioning elderly patients from thiazide diuretics to alternative agents when managing hypertension given the increased concern for hyponatremia in this patient population?
Do you have a preference between an ACEi and ARB when initiating therapy for a patient with diabetic kidney disease, albuminuria, and hypertension?
Do you take any special considerations when working up a pregnant patient for secondary causes of hypertension?
Can a dihydropyridine calcium channel blocker (CCB) like amlodipine be prescribed in addition to a non-dihydropyridine CCB such as diltiazem or verapamil for treating hypertension?
How do the results of the ESPRIT trial, which evaluated the impact of an SBP target of <120 mmHg on preventing major cardiovascular events, influence your blood pressure management goals for hypertensive patients with diabetes or a history of stroke?
What is your approach for patients who have marked inter-arm blood pressure differences on home and in office measurements?
How do you decide on the speed and target of blood pressure reduction for spontaneous intracranial hemorrhage?
Do you recommend patients with hypertensive kidney disease transition from wrist to upper-arm home blood pressure monitoring prior to making dose adjustments to their antihypertensive regimen?
What is your approach to initiating spironolactone in patients with end stage kidney disease and heart failure?
